| 汤钊猷 | 复旦大学附属中山医院：复旦大学肝癌研究所 | Anticancer: eradication, modulation and their integration |
| 王向东 | 复旦大学附属中山医院：复旦大学肝癌研究所 | Role of Clinical Bioinforamtics in the Development Network-based Biomarkers |
| Nagy Habib | 帝国理工大学 | Towards optimization of treatment of Hepatocellular carcinoma |
| 胡志鹏 | 贝克曼库尔特公司 | Single cell separation technology in the application of tumor targeted therapy |
| Yuzhuo Wang | 加拿大不列颠哥伦比亚省不列颠哥伦比亚癌症中心 | Next generation cancer models for discovery, translational research and beyond |
| 陈敏山 | 广州中山大学 | Expert consensus on the norms of local ablation therapy for liver cancer |
| 匡铭 | 广州中山大学 | Validation of ablation margin by using three dimensional reconstruction software: an initial |
| 卢大儒 | 复旦大学生命科学院 | Genetics of Lung cancer drugs |
| 夏景林 | 复旦大学附属中山医院：复旦大学肝癌研究所 | The role of anti-virus in hepatocellular carcinoma interventional therapy |
| 孙文兵 | 首都医科大学附属北京朝阳医院 | Overview of local ablation therapy in liver cancer management |